Wanbury shareholders approve FY26 financials, director re-appointments
- Shareholders adopted audited financial statements for FY26 at the 38th AGM held on September 24, 2026
- Re-appointment of Mr. Mohan Kumar Rayana as Whole-time Director until August 20, 2031, was approved
- Remuneration for M/s. ABK & Associates as Cost Auditor for FY27 was ratified
- Meeting conducted via video conferencing in compliance with SEBI Listing Regulations

*this image is generated using AI for illustrative purposes only.
Wanbury Limited shareholders approved the adoption of audited financial statements for the fiscal year ended March 31, 2026, during the company's 38th Annual General Meeting held on September 24, 2026. The meeting also ratified the remuneration of the cost auditor and approved the re-appointment of key directors.
The proceedings were conducted via Video Conferencing/Other Audio Visual Means, in compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mr. K. Chandran, Whole-time Director, presided over the meeting. Independent Directors Dr. Anupama Vaidya, Mr. Mridul S. Mehta, Mr. P.V. Shankar Dass, and Mr. Manojkumar K. Gursahani were also present.
Key resolutions passed
All resolutions put forth for shareholder approval were passed with the requisite majority following remote e-voting. The specific items of business included:
- Adoption of Financial Statements: Ordinary resolution to adopt the Audited Financial Statements for FY26 along with the Reports of Directors and Auditors.
- Director Re-appointment: Ordinary resolution for the re-appointment of Mr. K. Chandran as Director liable to retire by rotation.
- Cost Auditor Remuneration: Ordinary resolution ratifying the remuneration payable to M/s. ABK & Associates, Cost Accountants, for conducting the cost audit for FY27.
- Special Resolution for WTD: Special resolution for the re-appointment of Mr. Mohan Kumar Rayana as Whole-time Director and continuation of his role beyond the age of 70 years.
Governance and voting process
Ms. Kala Agarwal, Practicing Company Secretary, was appointed as the Scrutinizer to conduct the remote e-voting process. The Scrutinizer's report confirmed that all resolutions were passed fairly and transparently. The Company Secretary confirmed that voting results would be available on the company website within 48 hours of the meeting's conclusion.
The meeting commenced at 11:30 am and concluded at 12:35 pm. Queries raised by members were addressed to their satisfaction.
Director and auditor details
The new disclosure provides specific details regarding the appointments ratified during the AGM. Mr. Mohan Kumar Rayana (DIN: 07878975) was re-appointed as Whole-time Director, with his tenure extended from August 21, 2026, to August 20, 2031. He holds a B. Pharm degree from the University of Mumbai and has over 25 years of experience with Wanbury in advisory roles, focusing on business strategy, talent enrichment, and mergers and acquisitions.
M/s. ABK & Associates, established in 1989, was ratified as the Cost Auditor for FY27. The firm has over 35 years of professional experience and serves clients across diverse industries including pharmaceuticals, automobiles, and engineering. Both the director and the auditing firm are not related to any other directors of the company and are not debarred from holding office by any regulatory authority.
Historical Stock Returns for Wanbury
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -3.41% | +1.15% | -14.99% | -4.66% | -9.78% | +183.21% |
How will the extension of Mr. Mohan Kumar Rayana's tenure as Whole-time Director beyond age 70 influence Wanbury's long-term strategic direction and succession planning?
What specific growth initiatives or M&A activities is Wanbury planning to pursue under the continued leadership of its senior directors?
How does the ratification of the cost auditor for FY27 reflect on Wanbury's operational efficiency and cost management strategies in the pharmaceutical sector?
































